Area of research
Endocrinology, Diabetes and Metabolism · Physiology
Research interest
Research interests include Diabetes Treatment and Management, Diet and metabolism studies, Bariatric Surgery and Outcomes, and Diabetes Management and Research.
Orforglipron, an oral small-molecule GLP-1 receptor agonist, for the treatment of obesity in people with type 2 diabetes (ATTAIN-2): a phase 3, double-blind, randomised, multicentre, placebo-controlled trial
Dapagliflozin effects on haematocrit, red blood cell count and reticulocytes in insulin-treated patients with type 2 diabetes
Preventive medicine of von Hippel–Lindau disease-associated pancreatic neuroendocrine tumors
Combined immune checkpoint blockade (anti-PD-1/anti-CTLA-4): Evaluation and management of adverse drug reactions
Diagnosis, monitoring and management of immune-related adverse drug reactions of anti-PD-1 antibody therapy